CANF
Can-Fite BioPharma
CANF
CANF
14 hedge funds and large institutions have $194K invested in Can-Fite BioPharma in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$22.6K | |
| 2 | +$20K | |
| 3 | +$16.9K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$15.7K |
| 5 |
CAM
Costello Asset Management
Feasterville,
Pennsylvania
|
+$1.48K |
Top Sellers
| 1 | -$31.5K | |
| 2 | -$13.8K | |
| 3 | -$5.53K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.85K |
| 5 |
Citigroup
New York
|
-$899 |
